Pentixapharm Holding Ag (PTP.D.IX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 9,701 |
| Marketable Securities | 531 |
| Other current assets | 8,479 |
| TOTAL | $18,711 |
| Non-Current Assets | |
| PPE Net | 324 |
| Intangibles | 52,565 |
| Other Non-Current Assets | 1,798 |
| TOTAL | $54,687 |
| Total Assets | $73,398 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 2,542 |
| Other current liabilities | 6,795 |
| TOTAL | $9,397 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 6,643 |
| TOTAL | $15,520 |
| Total Liabilities | $24,917 |
| Shareholders' Equity | |
| Common Shares | 21,700 |
| Retained earnings | 2,129 |
| TOTAL | $48,481 |
| Total Liabilities And Equity | $73,398 |